©2017 BY EPISCI

Molecule

BIOMARKERS

epiSCI is undertaking a systematic analysis of cancer stem cell markers, accumulating a knowledge database for over 200 cancer indications and the associated normal epithelial stem cells identifying druggable carcinogenic pathways that distinguish cancer stem cells from normal stem cells.

Our goal is to develop novel commercial applications of stem cell biomarkers for therapeutics, diagnostics and targeted drug delivery.

​

Join us to obtain valuable information about the toxicity and specificity of your targeted pathway
 

  • Home

  • The epiSCI difference

  • biomarkers

  • In the pipeline

  • Resources

  • Research

  • Contact

  • More

    new7.png

    EPISCI: EPITHELIAL STEM CELL INNOVATION

    The right in vitro platform to develop the right drug, delivered to the right cells,

    in the right patient.

    Clinical Trial on a Dish (TM)

    ​

    Get In Touch